| Histologic heterogeneity of triple negative breast cancer: A National Cancer Centre Database analysis MN Mills, GQ Yang, DE Oliver, CL Liveringhouse, KA Ahmed, AG Orman, ... European journal of cancer 98, 48-58, 2018 | 92 | 2018 |
| Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial S Kim, E Wuthrick, D Blakaj, Z Eroglu, C Verschraegen, R Thapa, M Mills, ... The Lancet 400 (10357), 1008-1019, 2022 | 83 | 2022 |
| Management of brain metastases in breast cancer: a review of current practices and emerging treatments MN Mills, NB Figura, JA Arrington, HHM Yu, AB Etame, MA Vogelbaum, ... Breast cancer research and treatment 180, 279-300, 2020 | 82 | 2020 |
| Retrospective analysis of technical success rate and procedure-related complications of 867 percutaneous CT-guided needle biopsies of lung lesions M Mills, J Choi, G El-Haddad, J Sweeney, B Biebel, L Robinson, ... Clinical radiology 72 (12), 1038-1046, 2017 | 53 | 2017 |
| Hepatic radioembolization from transradial access: initial experience and comparison to transfemoral access B Kis, M Mills, SE Hoffe Diagnostic and Interventional Radiology 22 (5), 444, 2016 | 52 | 2016 |
| Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer management KA Ahmed, CL Liveringhouse, MN Mills, NB Figura, GD Grass, ... EBioMedicine 47, 163-169, 2019 | 51 | 2019 |
| Methylation of immune synapse genes modulates tumor immunogenicity A Berglund, M Mills, RM Putney, I Hamaidi, J Mulé, S Kim The Journal of clinical investigation 130 (2), 974-980, 2020 | 42 | 2020 |
| Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastases MN Mills, C Walker, C Thawani, A Naz, NB Figura, S Kushchayev, ... BMC cancer 21, 1-8, 2021 | 30 | 2021 |
| Radiotherapy for early stage diffuse large B-cell lymphoma with or without double or triple hit genetic alterations GD Grass, MN Mills, KA Ahmed, CL Liveringhouse, MJ Montejo, ... Leukemia & lymphoma 60 (4), 886-893, 2019 | 19 | 2019 |
| Enhancement of the Follicular Lymphoma International Prognostic Index (FLIPI) with lymphopenia (FLIPI-L): a predictor for overall survival and histologic transformation G Yang, M Mills, Y Kim, NB Figura, C Doyle, D Oliver, GD Grass, ... Blood Cancer Journal 9 (12), 104, 2019 | 16 | 2019 |
| Stereotactic body radiation therapy in oligometastatic uterine cancer: clinical outcomes and toxicity AV Reddy, MN Mills, LB Reshko, K Martin Richardson, CR Kersh Cancer investigation 38 (8-9), 522-530, 2020 | 13 | 2020 |
| Evolving management of HER2+ breast cancer brain metastases and leptomeningeal disease MN Mills, W King, A Soyano, Y Pina, BJ Czerniecki, PA Forsyth, ... Journal of Neuro-Oncology 157 (2), 249-269, 2022 | 11 | 2022 |
| Partial splenic artery embolization in 35 cancer patients: results of a single institution retrospective study B Kis, M Mills, J Smith, J Choi, E Sagatys, R Komrokji, J Strosberg, ... Journal of Vascular and Interventional Radiology 31 (4), 584-591, 2020 | 11 | 2020 |
| Neoadjuvant simultaneous integrated boost radiation therapy improves clinical outcomes for retroperitoneal sarcoma CL Liveringhouse, RF Palm, JM Bryant, GQ Yang, MN Mills, ND Figura, ... International Journal of Radiation Oncology* Biology* Physics 117 (1), 123-138, 2023 | 9 | 2023 |
| Clinical outcomes of non–small cell lung cancer brain metastases treated with stereotactic radiosurgery and immune checkpoint inhibitors, EGFR tyrosine kinase inhibitors … AE Dohm, JD Tang, MN Mills, CL Liveringhouse, ML Sandoval, BA Perez, ... Journal of Neurosurgery 138 (6), 1600-1607, 2022 | 8 | 2022 |
| The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIs MN Mills, TK Potluri, Y Kawahara, M Fahey, NB Figura, AE Soyano, ... Breast Cancer Research and Treatment, 1-9, 2022 | 8 | 2022 |
| Breast cancer subtype predicts clinical outcomes after stereotactic radiation for brain metastases MN Mills, C Thawani, NB Figura, DE Oliver, AE Soyano, A Etame, ... Journal of Neuro-Oncology 152, 591-601, 2021 | 8 | 2021 |
| Stereotactic radiosurgery and anti-PD-1+ CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the … AE Dohm, JY Nakashima, H Kalagotla, SX Jiang, JD Tang, M Bhandari, ... European Journal of Cancer 192, 113287, 2023 | 7 | 2023 |
| Tucatinib and stereotactic radiosurgery in the management of HER2 positive breast cancer brain metastases VM Khatri, MN Mills, DE Oliver, HHM Yu, MA Vogelbaum, PA Forsyth, ... Journal of Neuro-Oncology 164 (1), 191-197, 2023 | 7 | 2023 |
| The prevalence of luminal B subtype is higher in older postmenopausal women with ER+/HER2-breast cancer and is associated with inferior outcomes M Mills, C Liveringhouse, F Lee, RH Nanda, KA Ahmed, IR Washington, ... Journal of geriatric oncology 12 (2), 219-226, 2021 | 7 | 2021 |
